APO Research
Talk to an analyst

APO RESEARCH · REPORT

Powerful Analgesics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Powerful Analgesics Industry Research Report 2026

29 December 2025143 pages

Choose your research edition.

Industry ResearchPowerful Analgesics Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Powerful Analgesics Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Powerful Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Powerful Analgesics Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Powerful Analgesics Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Powerful Analgesics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Powerful Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Powerful Analgesics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Powerful Analgesics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Powerful Analgesics include Sun Pharmaceutical Industries, Teva, Shandong Keyuan Pharmaceutical, Novartis, Mylan, Pfizer, Northeast Pharmaceutical Group, Watson Laboratories and Stada Arzneimittel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Powerful Analgesics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Powerful Analgesics Market by Company

Sun Pharmaceutical Industries

Teva

Shandong Keyuan Pharmaceutical

Novartis

Mylan

Pfizer

Northeast Pharmaceutical Group

Watson Laboratories

Stada Arzneimittel

Sanofi Winthrop Industrie

Purdue Pharma

Mundipharma

Mallinckrodt Pharmaceuticals

Macfarlan Smith

Lannett

KV Pharmaceutical

Johnson and Johnson

Fresenius

Endo Pharmaceuticals

Barr Pharmaceuticals

Apotex

Alcaliber

Akorn

Powerful Analgesics Segment by Type

Morphine

Oxymorphone

Hydromorphone

Others

Powerful Analgesics Segment by Application

Hospital

Clinic

Others

Powerful Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Powerful Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Powerful Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Powerful Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Powerful Analgesics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Powerful Analgesics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Powerful Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Powerful Analgesics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Powerful Analgesics Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Powerful Analgesics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Powerful Analgesics Revenue of Manufacturers (2021-2026) Table 9. Global Powerful Analgesics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Powerful Analgesics Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Powerful Analgesics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Powerful Analgesics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Powerful Analgesics, Product Type & Application Table 14. Global Powerful Analgesics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Powerful Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sun Pharmaceutical Industries Company Information Table 19. Sun Pharmaceutical Industries Business Overview Table 20. Sun Pharmaceutical Industries Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Sun Pharmaceutical Industries Powerful Analgesics Product Portfolio Table 22. Sun Pharmaceutical Industries Recent Developments Table 23. Teva Company Information Table 24. Teva Business Overview Table 25. Teva Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Teva Powerful Analgesics Product Portfolio Table 27. Teva Recent Developments Table 28. Shandong Keyuan Pharmaceutical Company Information Table 29. Shandong Keyuan Pharmaceutical Business Overview Table 30. Shandong Keyuan Pharmaceutical Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shandong Keyuan Pharmaceutical Powerful Analgesics Product Portfolio Table 32. Shandong Keyuan Pharmaceutical Recent Developments Table 33. Novartis Company Information Table 34. Novartis Business Overview Table 35. Novartis Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Novartis Powerful Analgesics Product Portfolio Table 37. Novartis Recent Developments Table 38. Mylan Company Information Table 39. Mylan Business Overview Table 40. Mylan Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Mylan Powerful Analgesics Product Portfolio Table 42. Mylan Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pfizer Powerful Analgesics Product Portfolio Table 47. Pfizer Recent Developments Table 48. Northeast Pharmaceutical Group Company Information Table 49. Northeast Pharmaceutical Group Business Overview Table 50. Northeast Pharmaceutical Group Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Northeast Pharmaceutical Group Powerful Analgesics Product Portfolio Table 52. Northeast Pharmaceutical Group Recent Developments Table 53. Watson Laboratories Company Information Table 54. Watson Laboratories Business Overview Table 55. Watson Laboratories Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Watson Laboratories Powerful Analgesics Product Portfolio Table 57. Watson Laboratories Recent Developments Table 58. Stada Arzneimittel Company Information Table 59. Stada Arzneimittel Business Overview Table 60. Stada Arzneimittel Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Stada Arzneimittel Powerful Analgesics Product Portfolio Table 62. Stada Arzneimittel Recent Developments Table 63. Sanofi Winthrop Industrie Company Information Table 64. Sanofi Winthrop Industrie Business Overview Table 65. Sanofi Winthrop Industrie Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sanofi Winthrop Industrie Powerful Analgesics Product Portfolio Table 67. Sanofi Winthrop Industrie Recent Developments Table 68. Purdue Pharma Company Information Table 69. Purdue Pharma Business Overview Table 70. Purdue Pharma Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Purdue Pharma Powerful Analgesics Product Portfolio Table 72. Purdue Pharma Recent Developments Table 73. Mundipharma Company Information Table 74. Mundipharma Business Overview Table 75. Mundipharma Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Mundipharma Powerful Analgesics Product Portfolio Table 77. Mundipharma Recent Developments Table 78. Mallinckrodt Pharmaceuticals Company Information Table 79. Mallinckrodt Pharmaceuticals Business Overview Table 80. Mallinckrodt Pharmaceuticals Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Mallinckrodt Pharmaceuticals Powerful Analgesics Product Portfolio Table 82. Mallinckrodt Pharmaceuticals Recent Developments Table 83. Macfarlan Smith Company Information Table 84. Macfarlan Smith Business Overview Table 85. Macfarlan Smith Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Macfarlan Smith Powerful Analgesics Product Portfolio Table 87. Macfarlan Smith Recent Developments Table 88. Lannett Company Information Table 89. Lannett Business Overview Table 90. Lannett Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Lannett Powerful Analgesics Product Portfolio Table 92. Lannett Recent Developments Table 93. KV Pharmaceutical Company Information Table 94. KV Pharmaceutical Business Overview Table 95. KV Pharmaceutical Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. KV Pharmaceutical Powerful Analgesics Product Portfolio Table 97. KV Pharmaceutical Recent Developments Table 98. Johnson and Johnson Company Information Table 99. Johnson and Johnson Business Overview Table 100. Johnson and Johnson Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Johnson and Johnson Powerful Analgesics Product Portfolio Table 102. Johnson and Johnson Recent Developments Table 103. Fresenius Company Information Table 104. Fresenius Business Overview Table 105. Fresenius Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Fresenius Powerful Analgesics Product Portfolio Table 107. Fresenius Recent Developments Table 108. Endo Pharmaceuticals Company Information Table 109. Endo Pharmaceuticals Business Overview Table 110. Endo Pharmaceuticals Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Endo Pharmaceuticals Powerful Analgesics Product Portfolio Table 112. Endo Pharmaceuticals Recent Developments Table 113. Barr Pharmaceuticals Company Information Table 114. Barr Pharmaceuticals Business Overview Table 115. Barr Pharmaceuticals Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Barr Pharmaceuticals Powerful Analgesics Product Portfolio Table 117. Barr Pharmaceuticals Recent Developments Table 118. Apotex Company Information Table 119. Apotex Business Overview Table 120. Apotex Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Apotex Powerful Analgesics Product Portfolio Table 122. Apotex Recent Developments Table 123. Alcaliber Company Information Table 124. Alcaliber Business Overview Table 125. Alcaliber Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Alcaliber Powerful Analgesics Product Portfolio Table 127. Alcaliber Recent Developments Table 128. Akorn Company Information Table 129. Akorn Business Overview Table 130. Akorn Powerful Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Akorn Powerful Analgesics Product Portfolio Table 132. Akorn Recent Developments Table 133. Global Powerful Analgesics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Powerful Analgesics Sales by Region (2021-2026) & (K Units) Table 135. Global Powerful Analgesics Sales Market Share by Region (2021-2026) Table 136. Global Powerful Analgesics Sales by Region (2027-2032) & (K Units) Table 137. Global Powerful Analgesics Sales Market Share by Region (2027-2032) Table 138. Global Powerful Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Powerful Analgesics Revenue Market Share by Region (2021-2026) Table 140. Global Powerful Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Powerful Analgesics Revenue Market Share by Region (2027-2032) Table 142. North America Powerful Analgesics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 144. North America Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 145. North America Powerful Analgesics Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Powerful Analgesics Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Powerful Analgesics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 149. Europe Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 150. Europe Powerful Analgesics Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Powerful Analgesics Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Powerful Analgesics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 154. Asia Pacific Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 155. Asia Pacific Powerful Analgesics Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Powerful Analgesics Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Powerful Analgesics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 159. South America Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 160. South America Powerful Analgesics Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Powerful Analgesics Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Powerful Analgesics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Powerful Analgesics Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Powerful Analgesics Sales by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Powerful Analgesics Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Powerful Analgesics Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Powerful Analgesics Sales by Type (2021-2026) & (K Units) Table 168. Global Powerful Analgesics Sales by Type (2027-2032) & (K Units) Table 169. Global Powerful Analgesics Sales Market Share by Type (2021-2026) Table 170. Global Powerful Analgesics Sales Market Share by Type (2027-2032) Table 171. Global Powerful Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Powerful Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Powerful Analgesics Revenue Market Share by Type (2021-2026) Table 174. Global Powerful Analgesics Revenue Market Share by Type (2027-2032) Table 175. Global Powerful Analgesics Price by Type (2021-2026) & (US$/Unit) Table 176. Global Powerful Analgesics Price by Type (2027-2032) & (US$/Unit) Table 177. Global Powerful Analgesics Sales by Application (2021-2026) & (K Units) Table 178. Global Powerful Analgesics Sales by Application (2027-2032) & (K Units) Table 179. Global Powerful Analgesics Sales Market Share by Application (2021-2026) Table 180. Global Powerful Analgesics Sales Market Share by Application (2027-2032) Table 181. Global Powerful Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Powerful Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Powerful Analgesics Revenue Market Share by Application (2021-2026) Table 184. Global Powerful Analgesics Revenue Market Share by Application (2027-2032) Table 185. Global Powerful Analgesics Price by Application (2021-2026) & (US$/Unit) Table 186. Global Powerful Analgesics Price by Application (2027-2032) & (US$/Unit) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Powerful Analgesics Distributors List Table 190. Powerful Analgesics Customers List Table 191. Powerful Analgesics Industry Trends Table 192. Powerful Analgesics Industry Drivers Table 193. Powerful Analgesics Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Powerful Analgesics Product Image Figure 5. Global Powerful Analgesics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Powerful Analgesics Market Size (2021-2032) & (US$ Million) Figure 7. Global Powerful Analgesics Sales (2021-2032) & (K Units) Figure 8. Global Powerful Analgesics Average Price (US$/Unit) & (2021-2032) Figure 9. Morphine Product Image Figure 10. Oxymorphone Product Image Figure 11. Hydromorphone Product Image Figure 12. Others Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Others Product Image Figure 16. Global Powerful Analgesics Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Powerful Analgesics, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Powerful Analgesics Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Powerful Analgesics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Powerful Analgesics Sales by Region in 2025 Figure 22. Global Powerful Analgesics Revenue by Region in 2025 Figure 23. North America Powerful Analgesics Market Size by Country in 2025 Figure 24. North America Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 25. North America Powerful Analgesics Revenue Market Share by Country (2021-2032) Figure 26. United States Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Powerful Analgesics Market Size by Country in 2025 Figure 29. Europe Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 30. Europe Powerful Analgesics Revenue Market Share by Country (2021-2032) Figure 31. Germany Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Powerful Analgesics Market Size by Country in 2025 Figure 37. Asia Pacific Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Powerful Analgesics Revenue Market Share by Country (2021-2032) Figure 39. China Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Powerful Analgesics Market Size by Country in 2025 Figure 48. South America Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 49. South America Powerful Analgesics Revenue Market Share by Country (2021-2032) Figure 50. Mexico Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Powerful Analgesics Market Size by Country in 2025 Figure 54. Middle East and Africa Powerful Analgesics Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Powerful Analgesics Revenue Market Share by Country (2021-2032) Figure 56. Turkey Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Powerful Analgesics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Powerful Analgesics Sales Market Share by Type (2021-2032) Figure 60. Global Powerful Analgesics Revenue Market Share by Type (2021-2032) Figure 61. Global Powerful Analgesics Price (US$/Unit) by Type (2021-2032) Figure 62. Global Powerful Analgesics Sales Market Share by Application (2021-2032) Figure 63. Global Powerful Analgesics Revenue Market Share by Application (2021-2032) Figure 64. Global Powerful Analgesics Price (US$/Unit) by Application (2021-2032) Figure 65. Powerful Analgesics Value Chain Figure 66. Powerful Analgesics Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Powerful Analgesics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Morphine
  • Oxymorphone
  • Hydromorphone
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Teva
  • Shandong Keyuan Pharmaceutical
  • Novartis
  • Mylan
  • Pfizer
  • Northeast Pharmaceutical Group
  • Watson Laboratories
  • Stada Arzneimittel
  • Sanofi Winthrop Industrie
  • Purdue Pharma
  • Mundipharma
  • Mallinckrodt Pharmaceuticals
  • Macfarlan Smith
  • Lannett
  • KV Pharmaceutical
  • Johnson and Johnson
  • Fresenius
  • Endo Pharmaceuticals
  • Barr Pharmaceuticals
  • Apotex
  • Alcaliber
  • Akorn

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Powerful Analgesics Market Size (2021-2032)
  4. 2.2.2 Global Powerful Analgesics Sales (2021-2032)
  5. 2.2.3 Global Powerful Analgesics Market Average Price (2021-2032)
  6. 2.3 Powerful Analgesics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Morphine
  9. 2.3.3 Oxymorphone
  10. 2.3.4 Hydromorphone
  11. 2.3.5 Others
  12. 2.4 Powerful Analgesics by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Clinic
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Powerful Analgesics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Powerful Analgesics Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Powerful Analgesics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Powerful Analgesics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Powerful Analgesics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Powerful Analgesics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Powerful Analgesics, Product Type & Application
  8. 3.8 Global Manufacturers of Powerful Analgesics, Established Date
  9. 3.9 Global Powerful Analgesics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sun Pharmaceutical Industries
  2. 4.1.1 Sun Pharmaceutical Industries Company Information
  3. 4.1.2 Sun Pharmaceutical Industries Business Overview
  4. 4.1.3 Sun Pharmaceutical Industries Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sun Pharmaceutical Industries Powerful Analgesics Product Portfolio
  6. 4.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 4.2 Teva
  8. 4.2.1 Teva Company Information
  9. 4.2.2 Teva Business Overview
  10. 4.2.3 Teva Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Teva Powerful Analgesics Product Portfolio
  12. 4.2.5 Teva Recent Developments
  13. 4.3 Shandong Keyuan Pharmaceutical
  14. 4.3.1 Shandong Keyuan Pharmaceutical Company Information
  15. 4.3.2 Shandong Keyuan Pharmaceutical Business Overview
  16. 4.3.3 Shandong Keyuan Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shandong Keyuan Pharmaceutical Powerful Analgesics Product Portfolio
  18. 4.3.5 Shandong Keyuan Pharmaceutical Recent Developments
  19. 4.4 Novartis
  20. 4.4.1 Novartis Company Information
  21. 4.4.2 Novartis Business Overview
  22. 4.4.3 Novartis Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novartis Powerful Analgesics Product Portfolio
  24. 4.4.5 Novartis Recent Developments
  25. 4.5 Mylan
  26. 4.5.1 Mylan Company Information
  27. 4.5.2 Mylan Business Overview
  28. 4.5.3 Mylan Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Mylan Powerful Analgesics Product Portfolio
  30. 4.5.5 Mylan Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Powerful Analgesics Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 Northeast Pharmaceutical Group
  38. 4.7.1 Northeast Pharmaceutical Group Company Information
  39. 4.7.2 Northeast Pharmaceutical Group Business Overview
  40. 4.7.3 Northeast Pharmaceutical Group Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Northeast Pharmaceutical Group Powerful Analgesics Product Portfolio
  42. 4.7.5 Northeast Pharmaceutical Group Recent Developments
  43. 4.8 Watson Laboratories
  44. 4.8.1 Watson Laboratories Company Information
  45. 4.8.2 Watson Laboratories Business Overview
  46. 4.8.3 Watson Laboratories Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Watson Laboratories Powerful Analgesics Product Portfolio
  48. 4.8.5 Watson Laboratories Recent Developments
  49. 4.9 Stada Arzneimittel
  50. 4.9.1 Stada Arzneimittel Company Information
  51. 4.9.2 Stada Arzneimittel Business Overview
  52. 4.9.3 Stada Arzneimittel Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Stada Arzneimittel Powerful Analgesics Product Portfolio
  54. 4.9.5 Stada Arzneimittel Recent Developments
  55. 4.10 Sanofi Winthrop Industrie
  56. 4.10.1 Sanofi Winthrop Industrie Company Information
  57. 4.10.2 Sanofi Winthrop Industrie Business Overview
  58. 4.10.3 Sanofi Winthrop Industrie Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sanofi Winthrop Industrie Powerful Analgesics Product Portfolio
  60. 4.10.5 Sanofi Winthrop Industrie Recent Developments
  61. 4.11 Purdue Pharma
  62. 4.11.1 Purdue Pharma Company Information
  63. 4.11.2 Purdue Pharma Business Overview
  64. 4.11.3 Purdue Pharma Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Purdue Pharma Powerful Analgesics Product Portfolio
  66. 4.11.5 Purdue Pharma Recent Developments
  67. 4.12 Mundipharma
  68. 4.12.1 Mundipharma Company Information
  69. 4.12.2 Mundipharma Business Overview
  70. 4.12.3 Mundipharma Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Mundipharma Powerful Analgesics Product Portfolio
  72. 4.12.5 Mundipharma Recent Developments
  73. 4.13 Mallinckrodt Pharmaceuticals
  74. 4.13.1 Mallinckrodt Pharmaceuticals Company Information
  75. 4.13.2 Mallinckrodt Pharmaceuticals Business Overview
  76. 4.13.3 Mallinckrodt Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Mallinckrodt Pharmaceuticals Powerful Analgesics Product Portfolio
  78. 4.13.5 Mallinckrodt Pharmaceuticals Recent Developments
  79. 4.14 Macfarlan Smith
  80. 4.14.1 Macfarlan Smith Company Information
  81. 4.14.2 Macfarlan Smith Business Overview
  82. 4.14.3 Macfarlan Smith Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Macfarlan Smith Powerful Analgesics Product Portfolio
  84. 4.14.5 Macfarlan Smith Recent Developments
  85. 4.15 Lannett
  86. 4.15.1 Lannett Company Information
  87. 4.15.2 Lannett Business Overview
  88. 4.15.3 Lannett Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Lannett Powerful Analgesics Product Portfolio
  90. 4.15.5 Lannett Recent Developments
  91. 4.16 KV Pharmaceutical
  92. 4.16.1 KV Pharmaceutical Company Information
  93. 4.16.2 KV Pharmaceutical Business Overview
  94. 4.16.3 KV Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 KV Pharmaceutical Powerful Analgesics Product Portfolio
  96. 4.16.5 KV Pharmaceutical Recent Developments
  97. 4.17 Johnson and Johnson
  98. 4.17.1 Johnson and Johnson Company Information
  99. 4.17.2 Johnson and Johnson Business Overview
  100. 4.17.3 Johnson and Johnson Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Johnson and Johnson Powerful Analgesics Product Portfolio
  102. 4.17.5 Johnson and Johnson Recent Developments
  103. 4.18 Fresenius
  104. 4.18.1 Fresenius Company Information
  105. 4.18.2 Fresenius Business Overview
  106. 4.18.3 Fresenius Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Fresenius Powerful Analgesics Product Portfolio
  108. 4.18.5 Fresenius Recent Developments
  109. 4.19 Endo Pharmaceuticals
  110. 4.19.1 Endo Pharmaceuticals Company Information
  111. 4.19.2 Endo Pharmaceuticals Business Overview
  112. 4.19.3 Endo Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Endo Pharmaceuticals Powerful Analgesics Product Portfolio
  114. 4.19.5 Endo Pharmaceuticals Recent Developments
  115. 4.20 Barr Pharmaceuticals
  116. 4.20.1 Barr Pharmaceuticals Company Information
  117. 4.20.2 Barr Pharmaceuticals Business Overview
  118. 4.20.3 Barr Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Barr Pharmaceuticals Powerful Analgesics Product Portfolio
  120. 4.20.5 Barr Pharmaceuticals Recent Developments
  121. 4.21 Apotex
  122. 4.21.1 Apotex Company Information
  123. 4.21.2 Apotex Business Overview
  124. 4.21.3 Apotex Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Apotex Powerful Analgesics Product Portfolio
  126. 4.21.5 Apotex Recent Developments
  127. 4.22 Alcaliber
  128. 4.22.1 Alcaliber Company Information
  129. 4.22.2 Alcaliber Business Overview
  130. 4.22.3 Alcaliber Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Alcaliber Powerful Analgesics Product Portfolio
  132. 4.22.5 Alcaliber Recent Developments
  133. 4.23 Akorn
  134. 4.23.1 Akorn Company Information
  135. 4.23.2 Akorn Business Overview
  136. 4.23.3 Akorn Powerful Analgesics Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Akorn Powerful Analgesics Product Portfolio
  138. 4.23.5 Akorn Recent Developments
5 Global Powerful Analgesics Market Scenario by Region
  1. 5.1 Global Powerful Analgesics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Powerful Analgesics Sales by Region: 2021-2032
  3. 5.2.1 Global Powerful Analgesics Sales by Region: 2021-2026
  4. 5.2.2 Global Powerful Analgesics Sales by Region: 2027-2032
  5. 5.3 Global Powerful Analgesics Revenue by Region: 2021-2032
  6. 5.3.1 Global Powerful Analgesics Revenue by Region: 2021-2026
  7. 5.3.2 Global Powerful Analgesics Revenue by Region: 2027-2032
  8. 5.4 North America Powerful Analgesics Market Facts & Figures by Country
  9. 5.4.1 North America Powerful Analgesics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Powerful Analgesics Sales by Country (2021-2032)
  11. 5.4.3 North America Powerful Analgesics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Powerful Analgesics Market Facts & Figures by Country
  15. 5.5.1 Europe Powerful Analgesics Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Powerful Analgesics Sales by Country (2021-2032)
  17. 5.5.3 Europe Powerful Analgesics Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Powerful Analgesics Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Powerful Analgesics Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Powerful Analgesics Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Powerful Analgesics Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Powerful Analgesics Market Facts & Figures by Country
  35. 5.7.1 South America Powerful Analgesics Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Powerful Analgesics Sales by Country (2021-2032)
  37. 5.7.3 South America Powerful Analgesics Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Powerful Analgesics Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Powerful Analgesics Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Powerful Analgesics Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Powerful Analgesics Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Powerful Analgesics Sales by Type (2021-2032)
  2. 6.1.1 Global Powerful Analgesics Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Powerful Analgesics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Powerful Analgesics Revenue by Type (2021-2032)
  5. 6.2.1 Global Powerful Analgesics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Powerful Analgesics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Powerful Analgesics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Powerful Analgesics Sales by Application (2021-2032)
  2. 7.1.1 Global Powerful Analgesics Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Powerful Analgesics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Powerful Analgesics Revenue by Application (2021-2032)
  5. 7.2.1 Global Powerful Analgesics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Powerful Analgesics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Powerful Analgesics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Powerful Analgesics Value Chain Analysis
  2. 8.1.1 Powerful Analgesics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Powerful Analgesics Production Mode & Process
  5. 8.2 Powerful Analgesics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Powerful Analgesics Distributors
  8. 8.2.3 Powerful Analgesics Customers
9 Global Powerful Analgesics Analyzing Market Dynamics
  1. 9.1 Powerful Analgesics Industry Trends
  2. 9.2 Powerful Analgesics Industry Drivers
  3. 9.3 Powerful Analgesics Industry Opportunities and Challenges
  4. 9.4 Powerful Analgesics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst